首页> 外国专利> Metabolic pathway engineering to increase production of ascorbic acid intermediates

Metabolic pathway engineering to increase production of ascorbic acid intermediates

机译:代谢途径工程可提高抗坏血酸中间体的产量

摘要

In recombinant microorganisms which were rendered capable of converting 2,5-diketo-D-gluconic acid (2,5-DKG) to 2-keto-L-gulonic acid (2-KLG) by transfer of genetic material, the secondary metabolites and metabolic pathways leading to the metabolic diversion of 2-KLG and 2,5- DKG were determined, and the diversion of 2-KLG to L-iodonic acid (IA) or of 2,5-DKG to 5-keto-D-gluconate (5-KDH) was blocked.
机译:在重组微生物中,这些微生物能够通过遗传物质,次生代谢产物和代谢物的转移将2,5-二酮-D-葡萄糖酸(2,5-DKG)转化为2-酮-L-古洛糖酸(2-KLG)。确定了导致2-KLG和2,5-DKG代谢转移的代谢途径,并将2-KLG转移至L-碘酸(IA)或将2,5-DKG转移至5-酮-D-葡萄糖酸酯(5-KDH)被阻止。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号